Page 136 - SAMRC Annual Report 2023-24
P. 136

Precision and Genomic
                                                               Medicine Research Unit






                                                               Unit director:
                                                               Prof. Raj Ramesar







            Prioritising responsive research                   patients from the total colorectal cancer patient
            through impactful interventions                    burden, and (ii) developing a technology based
                                                               on cell free (circulating) RNA/DNA to potentially
            The objectives of the Precision and Genomic Medicine   replace colonoscopies to identify neoplasm-linked
            Research Unit were: (1) to expand our work into the   biomarkers.
            indigenous population of the Eastern Cape, notably
            with  regards  to  large  scale  psychiatric  genomics   Equitable capacity development
            research of schizophrenia in that community. This is a
            neglected community and stands to remain distal to   for empowering communities
            the advancements coming out of the major progresses   Our capacity development initiatives in the unit
            being  achieved  in  first  world  populations  that  are   are  driven by  a commitment  to training  and
            being researched using this powerful technology.   promoting equity in health research. The Human
            We have established a research infrastructure with   Genetics Division is focused on creating sustainable
            colleagues in the Eastern Cape and have recruited   capacity development programmes that align with
            approximately 4000 cases and controls and we are   our research translational goals. Our BSc Hons
            busy doing Whole Exome Sequencing and Whole        programme, which consists of four mandatory
            Genome sequencing on these. (2) to improve the     modules, including two on bioinformatics and data
            diagnostics  of  inherited  retinal  diseases  (IRDs),  for   analytics, alongside two electives and a laboratory-
            which we are a national centre of excellence, by   based  research  project  is  key.  This  programme
            making a concerted effort to work in our indigenous   serves as an entry point for students into our research
            communities. (3) having worked on the genetics of   projects and provides a pathway for our illustrious
            hereditary colorectal cancers extensively amongst   MSc and PhD studies. While we are inundated with
            the rural communities of the Northern and Western   applicants from historically advantaged institutions,
            Cape Provinces, and shown the power of precision/  we have been successful in attracting postgraduate
            personalised medicine to (a) identify the genetic   students from underrepresented institutions and
            basis of disease in affected patients, and (b) to   keeping our student profile as diverse as the peoples
            afford predictive genetic testing in their first degree   of this country.
            relatives, and presymptomatic clinical surveillance,
            which has resulted in improved both morbidity and   Another  of  our  significant  achievements  is  the
            mortality, and (c) be a major cost saver (in a formal   internationally  recognised  MSc  programme  in
            cost-benefit health economics study.               Genetic Counselling. This programme emerged
                                                               from our research into hereditary diseases,
            Our ongoing work for 2023/2024 has focused on: (i)   specifically  Inherited  Retinal  Diseases  and  Familial
            developing a regression scoring tool, (and turning   Colorectal Cancer. These studies identified extensive
            this into an app available on our mobile phones),   familial lineages with high rates of these disorders,
            to be used by the managing multidisciplinary       emphasising the need for genetic counselling to
            team  to  ascertain  the  familial  colorectal  cancer   help affected families understand diagnostic and





            134         SAMRC  ANNUAL REPOR T 2023-24
   131   132   133   134   135   136   137   138   139   140   141